Carisma Therapeutics Inc.
Board Member
2023-03-07–present
Board Member
Carisma Therapeutics Inc.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Briggs Morrison is recorded as Board Member at Carisma Therapeutics Inc.. Carisma Therapeutics Inc. reported in an 8-K filed October 15, 2025 that Briggs Morrison resigned as director, effective October 15, 2025. Carisma Therapeutics Inc. reported in an 8-K filed March 8, 2023 that Briggs Morrison was appointed Board, effective March 7, 2023.
“On October 14, 2025, each of John Hohneker, M.D., Briggs Morrison, M.D. and David Scadden M.D. notified the Company of such director's decision to resign from the Company's board of directors (the "Board") and all committees thereof, effective October 15, 2025.”
“the Board and its committees were reconstituted, consisting of six directors designated by Carisma, who are Steven Kelly, Regina Hodits, Ph.D., Briggs Morrison, M.D., Björn Odlander, M.D., Ph.D., Chidozie Ugwumba and Sanford Zweifach, and one director designated by the Company, who is Michael Torok.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
Carisma Therapeutics Inc.
Board Member
SEC 8-K
2023-03-07–present
Carisma Therapeutics Inc.
Board Member
SEC 8-K
2023-03-07–2025-10-15
Recorded roles and call appearances connecting this person to public companies.
Carisma Therapeutics Inc.
Board Member
2023-03-07–present
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.